Maternus-Kliniken Aktiengesellschaft
FSX:MAK.DE
1.15 (EUR) • At close August 29, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 114.004 | 102.306 | 106.697 | 111.437 | 114.299 | 124.43 | 124.278 | 127.143 | 124.04 | 123.269 | 122.041 | 113.566 | 113.942 | 110.904 | 111.811 | 112.797 | 109.812 | 106.405 |
| Cost of Revenue
| 15.222 | 14.86 | 19.718 | 13.921 | 16.6 | 21.569 | 21.425 | 21.769 | 21.01 | 20.756 | 22.081 | 20.377 | 17.863 | 19.697 | 20.407 | 21.371 | 21.848 | 20.683 |
| Gross Profit
| 98.782 | 87.446 | 86.979 | 97.516 | 97.699 | 102.861 | 102.853 | 105.374 | 103.03 | 102.513 | 99.96 | 93.189 | 96.079 | 91.207 | 91.404 | 91.426 | 87.964 | 85.722 |
| Gross Profit Ratio
| 0.866 | 0.855 | 0.815 | 0.875 | 0.855 | 0.827 | 0.828 | 0.829 | 0.831 | 0.832 | 0.819 | 0.821 | 0.843 | 0.822 | 0.817 | 0.811 | 0.801 | 0.806 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 4.045 | 3.589 | 2.962 | 3.064 | 3.032 | 3.662 | 3.272 | 4.27 | 4.159 | 5.019 | 4.797 | 5.776 | 5.669 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 4.045 | 3.589 | 2.962 | 3.064 | 3.032 | 3.662 | 3.272 | 4.27 | 4.159 | 5.019 | 4.797 | 5.776 | 5.669 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 98.725 | 0 | 94.161 | 90.69 | 93.117 | 101.957 | 96.72 | 94.87 | 93.083 | 89.405 | 62.908 | 91.349 | 89.122 | -1.989 | -2.162 | -1.44 | 82.528 | 81.608 |
| Operating Expenses
| 102.77 | 96.707 | 97.123 | 93.754 | 96.149 | 105.619 | 99.992 | 99.14 | 97.242 | 94.424 | 67.705 | 97.125 | 94.791 | 86.084 | 83.671 | 84.467 | 82.528 | 81.608 |
| Operating Income
| -3.988 | -9.261 | -7.843 | 4.046 | -0.541 | -4.381 | 2.861 | 6.234 | 5.788 | 8.089 | 32.255 | -3.936 | 1.288 | 5.123 | 7.733 | 6.959 | -2.476 | -4.25 |
| Operating Income Ratio
| -0.035 | -0.091 | -0.074 | 0.036 | -0.005 | -0.035 | 0.023 | 0.049 | 0.047 | 0.066 | 0.264 | -0.035 | 0.011 | 0.046 | 0.069 | 0.062 | -0.023 | -0.04 |
| Total Other Income Expenses Net
| -6.287 | -3.322 | -4.935 | -3.151 | -5.869 | -8.281 | -5.585 | -5.368 | -5.71 | -5.219 | -4.733 | -6.831 | -9.298 | -7.168 | -7.15 | -5.867 | -5.453 | 0 |
| Income Before Tax
| -10.275 | -12.583 | -12.826 | -1.964 | -7.777 | -12.641 | -2.724 | 0.866 | 0.078 | 2.87 | 27.522 | -10.766 | -8.278 | -2.045 | 0.583 | 1.092 | -2.476 | -4.25 |
| Income Before Tax Ratio
| -0.09 | -0.123 | -0.12 | -0.018 | -0.068 | -0.102 | -0.022 | 0.007 | 0.001 | 0.023 | 0.226 | -0.095 | -0.073 | -0.018 | 0.005 | 0.01 | -0.023 | -0.04 |
| Income Tax Expense
| 2.882 | 1.674 | 1.251 | 0.521 | 1.845 | -2.385 | -1.15 | 2.322 | -1.026 | 0.512 | 0.678 | 1.959 | 0.322 | -0.157 | -1.396 | 0.206 | 0.266 | 0.027 |
| Net Income
| -13.157 | -14.257 | -14.077 | -2.485 | -9.622 | -10.256 | -1.575 | -1.456 | 1.104 | 2.358 | 26.844 | -12.725 | -8.599 | -1.888 | 1.979 | 0.886 | -2.742 | -4.277 |
| Net Income Ratio
| -0.115 | -0.139 | -0.132 | -0.022 | -0.084 | -0.082 | -0.013 | -0.011 | 0.009 | 0.019 | 0.22 | -0.112 | -0.075 | -0.017 | 0.018 | 0.008 | -0.025 | -0.04 |
| EPS
| -0.63 | -0.68 | -0.67 | -0.12 | -0.46 | -0.49 | -0.075 | -0.069 | 0.05 | 0.11 | 1.28 | -0.61 | -0.41 | -0.09 | 0.08 | 0.04 | -0.13 | -0.2 |
| EPS Diluted
| -0.63 | -0.68 | -0.67 | -0.12 | -0.46 | -0.49 | -0.075 | -0.069 | 0.05 | 0.11 | 1.28 | -0.61 | -0.41 | -0.09 | 0.08 | 0.04 | -0.13 | -0.2 |
| EBITDA
| 10.709 | 4.715 | 1.712 | 14.961 | 13.211 | 8.963 | 8.535 | 11.379 | 11.038 | 13.43 | 37.986 | 2.171 | 2.942 | 8.957 | 10.972 | 11.001 | 10.989 | 9.051 |
| EBITDA Ratio
| 0.094 | 0.046 | 0.016 | 0.134 | 0.116 | 0.072 | 0.069 | 0.089 | 0.089 | 0.109 | 0.311 | 0.019 | 0.026 | 0.081 | 0.098 | 0.098 | 0.1 | 0.085 |